leisure time -WSS

leisure time

author：leisure time 2025-08-26 23:48:50 - browse：49

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Some dementia cases could be undiagnosed liver disease

hotspot

focus

WSS

Novo Nordisk to expand supply of Wegovy for U.S. patients

Juul spent big to court Black leaders to promote its e

Novo Nordisk to expand supply of Wegovy for U.S. patients

Commercial surrogacy can be ethical, despite pope’s claims

Vertigo drug brings hope for rare neuron disorder, Niemann

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

leisure time

leisure time

focus

How to save PrEP access — and even expand it

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Drug repurposing or repositioning? The language matters

Some dementia cases could be undiagnosed liver disease

Peter Hotez and the public health issue of online harassment

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Medical records are filled with copy

Novo Nordisk to expand supply of Wegovy for U.S. patients

The high cost of giving birth even with insurance

Even great ERs can’t make up for American health disparities

hotspot

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Cognito secures funding to test medical device for Alzheimer's

Do digital therapeutics have a future in medicine?

Vertex non

FDA drug safety: Singulair case shows systemic surveillance flaws

Commercial surrogacy can be ethical, despite pope’s claims

hotspot

focus

focus

Wikipedia